A reactive oxygen species-mediated component in neurogenic vasodilatation

Cardiovascular Research

Volumn 78, Issue 1, 2008, Pages 139-147

  Starr, Anna ^a   Graepel, Rabea ^a   Keeble, Julie ^b   Schmidhuber, Sabine ^a   Clark, Natalie ^a   Grant, Andrew ^a   Shah, Ajay M ^a   Brain, Susan D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Capsaicin; CGRP; NADPH oxidase; Neurogenic vasodilatation; Reactive oxygen species; Substance P; TRPV1

Indexed keywords

APOCYNIN; CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; CATALASE; HYDROGEN PEROXIDE; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; PROSTAGLANDIN E1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUBSTANCE P; SUPEROXIDE DISMUTASE; VANILLOID RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DOPPLER FLOWMETER; ENZYME ACTIVATION; IN VIVO STUDY; INHIBITION KINETICS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; VASODILATATION;

ACETOPHENONES; ANIMALS; ANTIOXIDANTS; BLOOD FLOW VELOCITY; BLOOD VESSELS; CALCITONIN GENE-RELATED PEPTIDE; CAPSAICIN; CATALASE; EAR; INDOMETHACIN; LASER-DOPPLER FLOWMETRY; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NADPH OXIDASE; NEURONS, AFFERENT; NG-NITROARGININE METHYL ESTER; REACTIVE OXYGEN SPECIES; RECEPTORS, NEUROKININ-1; REGIONAL BLOOD FLOW; SUPEROXIDE DISMUTASE; TETRAETHYLAMMONIUM; TIME FACTORS; TRPV CATION CHANNELS; VASODILATION; VASODILATOR AGENTS;

EID: 41149128241     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn012     Document Type: Article

References (44)

1. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 1988;24:739-768.
2. Lembeck F, Holzer P. SP as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn Schmiedebergs Arch Pharmacol 1979;310:175-183.
3. Brain SD, Williams TJ, Tippins JR, Morris HR, MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature 1985;313:54- 56.
4. Bell D, McDermott BJ. Calcitonin gene-related peptide in the cardiovascular system: characterization of receptor populations and their (patho)-physiological significance. Pharmacol Rev 1996;48:253-288.
5. Brain SD, Grant AD. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 2004;84:903-934.
6. Rubino A, Burnstock G. Capsaicin-sensitive sensory-motor neurotransmission in the peripheral control of cardiovascular function. Cardiovasc Res 1996;31:467-479.
7. Wang DH. The vanilloid receptor and hypertension. Acta Pharmacol Sin 2005;26:286-294.
8. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997;389:816-824.
9. Szolcsanyi J. Forty years in capsaicin research for sensory pharmacology and physiology. Neuropeptides 2004;38:377-384.
10. Rang HP, Bevan S, Dray A. Chemical activation of nociceptive peripheral neurones. Br Med Bull 1991;47:534-548.
11. Cesare P, Moriondo A, Vellani V, McNaughton PA. Ion channels gated by heat. Proc Natl Acad Sci USA 1999;96:7658-7663.
12. De Petrocellis L, Di Marzo V. Lipids as regulators of the activity of transient receptor potential type V1 (TRPV1) channels. Life Sci 2005;77:1651-1666.
13. Strecker T, Messlinger K, Weyand M, Reeh PW. Role of different proton-sensitive channels in releasing calcitonin gene-related peptide from isolated hearts of mutant mice. Cardiovasc Res 2005;65:405-410.
14. Wang L, Wang DH. TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice. Circulation 2005;112:3617-3623.
15. Fragasso G, Palloshi A, Piatti PM, Monti L, Rossetti E, Setola E et al. Nitric-oxide mediated effects of transdermal capsaicin patches on the ischemic threshold in patients with stable coronary disease. J Cardiovasc Pharmacol 2004;44:340-347.
16. Keeble J, Russell F, Curtis B, Starr A, Pinter E, Brain SD. Involvement of transient receptor potential vanilloid 1 in the vascular and hyperalgesic components of joint inflammation. Arthritis Rheum 2005;52:3248- 3256.
17. Bozic CR, Lu B, Hopken UE, Gerard C, Gerard NP. Neurogenic amplification of immune complex inflammation. Science 1996;273:1722-1725.
18. Salmon AM, Damaj I, Sekine S, Picciotto MR, Marubio L, Changeux JP. Modulation of morphine analgesia in alphaCGRP mutant mice. Neuroreport 1999;10:849-854.
19. Bendall JK, Cave AC, Heymes C, Gall N, Shah AM. Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 2002;105:293-296.
20. Grant AD, Gerard NP, Brain SD. Evidence of a role for NK1 and CGRP receptors in mediating neurogenic vasodilatation in the mouse ear. Br J Pharmacol 2002;135:356-362.
21. Kramer HH, Schmidt K, Leis S, Schmelz M, Sommer C, Birklein F. Inhibition of neutral endopeptidase (NEP) facilitates neurogenic inflammation. Exp Neurol 2005;195:179-184.
22. Cao T, Gerard NP, Brain SD. Use of NK(1) knockout mice to analyze SP-induced edema formation. Am J Physiol 1999;277:R476-R481.
23. Cao T, Pinter E, Al Rashed S, Gerard N, Hoult JR, Brain SD. Neurokinin-1 receptor agonists are involved in mediating neutrophil accumulation in the inflamed, but not normal, cutaneous microvasculature: an in vivo study using neurokinin-1 receptor knockout mice. J Immunol 2000;164:5424-5429.
24. Doods H, Hallermayer G, Wu D, Entzeroth M, Rudolf K, Engel W. Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br J Pharmacol 2000;129:420-423.
25. Grant AD, Tam CW, Lazar Z, Shih MK, Brain SD. The calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS blocks CGRP and adrenomedullin vasoactive responses in the microvasculature. Br J Pharmacol 2004;142:1091-1098.
26. Fujii E, Irie K, Ohba K, Ogawa A, Yoshioka T, Yamakawa M et al. Role of nitric oxide, prostaglandins and tyrosine kinase in vascular endothelial growth factor-induced increase in vascular permeability in mouse skin. Naunyn Schmiedebergs Arch Pharmacol 1997;356:475-480.
27. Inokuchi K, Hirooka Y, Shimokawa H, Sakai K, Kishi T, Ito K et al. Role of endothelium-derived hyperpolarizing factor in human forearm circulation. Hypertension 2003;42:919-924.
28. Kimura S, Zhang GX, Nishiyama A, Ahokoji T, Yao L, Fan YY et al. Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II. Hypertension 2005;45:860-866.
29. Takeshita K, Takajo T, Hirata H, Ono M, Utsumi H. In vivo oxygen radical generation in the skin of the protoporphyria model mouse with visible light exposure: an L-band ESR study. J Invest Dermatol 2004;122:1463- 1470.
30. Sharma S, Grobe AC, Wiseman DA, Kumar S, Englaish M, Najwer I. Lung antioxidant enzymes are regulated by development and increased pulmonary blood flow. Am J Physiol Lung Cell Mol Physiol 2007;293:L960-L971.
31. Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U et al. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 2004;350:1104-1110.
32. Kramer MS, Winokur A, Kelsey J, Preskorn SH, Rothschild AJ, Snavely D et al. Demonstration of the efficacy and safety of a novel SP (NK1) receptor antagonist in major depression. Neuropsychopharmacology 2004;29:385-892.
33. Gulbenkian S, Saetrum OO, Ekman R, Costa Andrade N, Wharton J, Polak JM et al. Peptidergic innervation of human epicardial coronary arteries. Circ Res 1993;73:579-588.
34. Scotland RS, Chauhan S, Davis C, De Felipe C, Hunt S, Kabir J et al. Vanilloid receptor TRPV1, sensory C-fibers, and vascular autoregulation: a novel mechanism involved in myogenic constriction. Circ Res 2004;95:1027-1034.
35. Miller AA, Drummond GR, Sobey CG. Novel isoforms of NADPH-oxidase in cerebral vascular control. Pharmacol Ther 2006;111:928-948.
36. Shimokawa H, Matoba T. Hydrogen peroxide as an endothelium-derived hyperpolarizing factor. Pharmacol Res 2004;49:543-549.
37. Gamse R, Holzer P, Lembeck F. Decrease of SP in primary afferent neurones and impairment of neurogenic plasma extravasation by capsaicin. Br J Pharmacol 1980;68:207-213.
38. Goldstein DJ, Wang O, Gitter BD, Iyengar S. Dose-response study of the analgesic effect of lanepitant in patients with painful diabetic neuropathy. Clin Neuropharmacol 2001;24:16-22.
39. Diener HC. RPR100893, a substance-P antagonist, is not effective in the treatment of migraine attacks. Cephalalgia 2003;23:183-185.
40. Usatyuk PV, Vepa S, Watkins T, He D, Parinandi NL, Natarajan V. Redox regulation of reactive oxygen species-induced p38 MAP kinase activation and barrier dysfunction in lung microvascular endothelial cells. Antioxid Redox Signal 2003;5:723-730.
41. Park L, Anrather J, Zhou P, Frys K, Wang G, Iadecola C. Exogenous NADPH increases cerebral blood flow through NADPH oxidase-dependent and -independent mechanisms. Arterioscler Thromb Vasc Biol 2004;24:1860-1865.
42. Miller AA, Drummond GR, Schmidt HH, Sobey CG. NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries. Circ Res 2005;97:1055-1062.
43. Ray R, Shah AM. NADPH oxidase and endothelial cell function. Clin Sci (Lond) 2005;109:217-226.
44. De Petrocellis L, Di Marzo V. Lipids as regulators of the activity of transient receptor potential type V1 (TRPV1) channels. Life Sci 2005;77:1651-1666.